Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 17, 2011
Company's everolimus-eluting platinum chromium stent now being marketed in world's second-largest DES market.
-
Oct 14, 2011
Legislation is intended to streamline the medical device review and approval process, reduce regulatory delays and help new medical technologies safely and more expeditiously reach patients.
-
Oct 11, 2011
Boston Scientific will webcast its conference call with financial results and business highlights for Q3 2011 on Thursday, October 20. Learn how to tune in.
-
Oct 5, 2011
Third-generation bare-metal stent designed to offer improved acute performance in treating patients with coronary artery disease
-
Sep 29, 2011
Study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients
-
Sep 28, 2011
U.S. Court of Appeals for the Federal Circuit found in favor of the Company in a 1998 patent infringement suit involving Johnson & Johnson
-
Sep 19, 2011
Ultra-low profile, highly deliverable balloon dilatation catheter offers physicians exceptional performance in peripheral angioplasty procedures.
-
Sep 15, 2011
Company supports women's health through online community launched by American Urogynecologic Society (AUGS) at annual meeting.
-
Sep 13, 2011
Mahoney Has Served as Worldwide Chairman, Medical Device and Diagnostics Group, Johnson & Johnson
-
Sep 9, 2011
Boston Scientific Corporation (NYSE: BSX) today issued the following statement from John Pedersen, Senior Vice President and President of the Company's...